Search Results 451-460 of 17274 for egfr

1. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   EGFR TKIs must not be given concomitantly and should be used with caution in the 90 days after the last dose of rilvegostomig. Have had major surgical ...

2. A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology (Veri-T-001) - Mayo Clinic

   Participation eligibility · Estimated glomerular filtration rate (eGFR) [determined by the Modification of Diet in Renal Disease (MDRD) Study equation] < 30 ...

3. Frontotemporal dementia - Doctors and departments - Mayo Clinic

   Mayo Clinic staff actively research frontotemporal dementia and related conditions. Researchers study risk factors, causes, diagnostic techniques and treatment ...

4. A Phase III, Randomised Study Of Adjuvant Dato-DXd In Combination With Rilvegostomig Or Rilvegostomig Monotherapy Versus Standard Of Care, Following Complete Tumour Resection, In Participants With Stage I Adenocarcinoma NSCLC Who Are CtDNA-positive Or Have High-risk Pathological Features - Mayo Clinic

   Sensitizing EGFR mutation and/or ALK alteration 2. History of non-infectious ILD/pneumonitis that required steroids, has current ILD/pneumonitis, or has ...

5. A Study To Evaluate Agents To Treat Moderately Or Severely Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) <30 mL/min (including patients receiving hemodialysis or hemofiltration). Neutropenia (absolute neutrophil count ...

6. Study To Determine The Effectiveness And Safety Of Dupilumab In Adult And Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2. NOTE: If ... eGFR will be calculated using the Modification of Diet in Renal Disease ...

7. A Study To Evaluate The Safety And Effectiveness Of The Drug TTP399 To Target A1c In Type 2 Diabetics - Mayo Clinic

   Clinically significant abnormal lab values including eGFR <50ml/min/1.73m2, ALT, bilirubin or AST >1.5 X ULN, hypokalemia or other clinically significant ...

8. Establishing The Safety And Effectiveness Of Reloxaliase In Patients With Enteric Hyperoxaluria - Mayo Clinic

   Acute renal failure or estimated glomerular filtration rate (eGFR) < 30 mL/minute/1.73 m^2. Has a known genetic, congenital, or other cause of kidney stones ...

9. Daratumumab to Treat Active Lupus Nephritis - Mayo Clinic

   - eGFR ≥ 30 ml/min/SA. - Subjects should be able to give informed consent. Exclusion Criteria: - Pregnancy. - Hepatitis B or C, HIV - Anemia with Hgb < 8.0 ...

10. A Study Evaluating The Efficacy And Safety Of Obinutuzumab In Participants With Primary Membranous Nephropathy - Mayo Clinic

    eGFR ≥ 40 mL/min/1.73m^2 or qualified endogenous creatinine clearance ≥ 40 mL/min based on 24-hour urine collection during screening. eGFR is calculated ...